Selective estrogen receptor modulators: an alternative to hormone replacement therapy.
about
In Vitro Investigations on the Toxicity and Cell Death Induced by Tamoxifen on Two Non-Breast Cancer Cell Types.Protective effects of estrogen in a rat model of age-related cataracts.Tamoxifen-2-hydroxylpropyl-beta-cyclodextrin-aggregated nanoassembly for nonbreast estrogen-receptor-positive cancer therapy.Hormone replacement therapy and breast cancer.Effect of SERMs on breast tissue.Tolerability profile of SERMs.Treatment with bazedoxifene and conjugated estrogens results in regression of endometriosis in a murine model.Estrogen receptor activation and tardive dyskinesia.Modification of serum lipids and cardiovascular risk by estrogenic active compounds.Arterial calcification: a review of mechanisms, animal models, and the prospects for therapy.Activation of ERα is necessary for estradiol's anorexigenic effect in female rats.Estrogen replacement therapy and cardioprotection: mechanisms and controversies.Postmenopausal estrogen therapy and depressive symptoms in older women.The role for estrogen receptor-alpha and prolactin receptor in sex-dependent DEN-induced liver tumorigenesisPeritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.Identification and characterization of potential impurities in raloxifene hydrochlorideLasofoxifene (CP-336,156), a novel selective estrogen receptor modulator, in preclinical studies.Prognostic factors in paediatric anaplastic large cell lymphoma: role of ALK.Effect of a putative ERalpha antagonist, MPP, on food intake in cycling and ovariectomized ratsProtective actions of sex steroid hormones in Alzheimer's disease.Assessment of the estrogenic activities of chickpea (Cicer arietinum L) sprout isoflavone extract in ovariectomized rats.Synthesis and structure elucidation of some novel thiophene and benzothiophene derivatives as cytotoxic agents.Formononetin prevents ovariectomy-induced bone loss in rats.Herbal extract prevents bone loss in ovariectomized rats.Selective estrogen receptor modulators suppress mesangial cell collagen synthesis.Identification of selective estrogen receptor modulators by their gene expression fingerprints.Multiple-dose, safety, pharmacokinetics, and pharmacodynamics of a new selective estrogen receptor modulator, ERA-923, in healthy postmenopausal women.Effects of estrogen-progestin and raloxifene therapy on nitric oxide, prostacyclin and endothelin-1 synthesis.Comparative analysis of oestrogen and raloxifene effects on the phospholipid composition of high density lipoproteins in healthy postmenopausal women.Beneficial effects of raloxifene and atorvastatin on serum lipids and HDL phospholipids levels of postmenopausal women.Extending the benefits of adjuvant therapy in early HR+ breast cancer.Evidence of improved serum fatty acid profile of postmenopausal women receiving atorvastatin and raloxifene.
P2860
Q24806512-4CB44D4E-B079-4E6D-BD07-CF23987D77EDQ30748551-1173529A-04BC-4D9D-A185-62F85A303249Q33517164-0E58902C-7860-4470-AF75-2F501DDF26FBQ33542518-8241668E-B7A1-4541-A8BA-A4265691B326Q33757750-90AD665F-4770-4D69-B6A4-CC6EC2B99F17Q33757754-67396AD1-3D8D-43B1-8600-019228FB0146Q33888331-F897AB80-58E3-403E-B79A-94E80C9424F8Q33898374-BE29F4B8-04E3-44CC-88FC-D8F1A4331FA5Q33947465-170F6AC7-ED39-4C2D-A965-DDD53D995987Q34285067-747C71B8-0EA3-4439-A016-5F1BFDD6745AQ34316349-5EC24D06-61AD-4D82-A8FE-B8E4BBE1860CQ34557438-954E1CED-44CD-47AD-AB65-FA35EE05FBC9Q34746437-E4AC8162-BE81-4AE7-934D-3EBCDD2F33F6Q35144521-CCD6ED6F-F5AA-4639-B3BD-047B877FE6ADQ35934073-5143352C-F38F-407A-A197-FF33E9AE679AQ36248974-3CF57EF3-CFA8-4C45-9A31-8F85247D4E39Q36271670-3FAED055-1225-4C63-90ED-A19EB4D8F4C9Q36436653-AF94C031-22C4-41F6-B46B-11DDA90BED41Q37236020-E13BDD87-09E0-4759-B3B5-E6A41E2CEFF1Q37309638-2888DD95-2A6A-4F97-BD00-BCB71C0EC85BQ37728290-874A038E-D04C-436F-B5AD-B00ACEC2A82EQ38787651-5D890A84-0577-4833-9643-F4603313E8C0Q39710360-D34B7F65-2228-49CD-9DD3-B73FED14EAC7Q40609583-CA6A64A5-9707-47F0-8B28-1F15035FA5EEQ40864586-41032F32-A30D-4CA9-8440-04B0C1D3149BQ41728152-C81892F6-7BCB-4B96-9DC7-1885CE90AF10Q43878859-3F094FC0-73BE-48DE-A829-8E296E6E2C7CQ43934290-4C27C96D-982F-4BDC-9F2F-C0472A4F8733Q44693744-F41F57D1-3617-409C-AD50-8F2AC7239FFBQ44941532-31FF2F19-55E5-45EA-B2C4-20A23FD71CADQ46374997-CEDE132C-897C-4094-BE29-92F777C09F1CQ46720358-1D9D9F1F-1FF2-44EE-84E0-CC83905F9867
P2860
Selective estrogen receptor modulators: an alternative to hormone replacement therapy.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Selective estrogen receptor modulators: an alternative to hormone replacement therapy.
@en
type
label
Selective estrogen receptor modulators: an alternative to hormone replacement therapy.
@en
prefLabel
Selective estrogen receptor modulators: an alternative to hormone replacement therapy.
@en
P1476
Selective estrogen receptor modulators: an alternative to hormone replacement therapy.
@en
P2093
P356
10.3181/00379727-217-44204
P577
1998-01-01T00:00:00Z